Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Florida sues Biden administration over new transgender healthcare rule

Published 05/07/2024, 11:54 AM
Updated 05/07/2024, 12:00 PM
© Reuters. FILE PHOTO: Supporters of the drag community protest against Florida's 'Protection of Children' bill which would ban children at live adult performances, inside the state capitol in Tallahassee, Florida, U.S. April 25, 2023. REUTERS/Octavio Jones/File Pho

By Brendan Pierson

(Reuters) - Florida's top prosecutor and a Catholic medical group on Tuesday sued the Biden administration in an effort to block a rule that they say will force doctors to provide gender transition care against their judgment or face heavy penalties.

The lawsuit by Florida Attorney General Ashley Moody and the Catholic Medical Association (CMA), filed in federal court in Tampa, takes aim at a new rule published by the U.S. Department of Health and Services (HHS) on Monday that would ban discrimination in healthcare on the basis of gender identity.

The rule is based on an anti-discrimination provision within the Affordable Care Act, the national health insurance law better known as Obamacare, which forbids sex discrimination.

In their complaint, Moody and CMA say the new rule goes beyond the anti-discrimination law. They say it would force doctors to provide, and insurance to pay for, treatments including puberty blockers, hormones and surgeries for transgender minors and adults against their medical or ethical judgment.

They also said the rule conflicted with a Florida law banning such treatments, which are known as gender-affirming care, for minors.

"These rules trample states' power to protect their own citizens and we will not stand by as Biden tries, yet again, to use the force of the federal government to unlawfully stifle Florida’s effort to protect children," Moody said in a statement.

The plaintiffs claim that the rule is "arbitrary and capricious" under a federal law governing agency rulemaking, and violates doctors' right to free speech and freedom of religion under the First Amendment of the U.S. Constitution. They are asking the court for an order blocking its enforcement.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

HHS said not immediately respond to a request for comment.

The agency and major medical organizations such as the American Academy of Pediatrics have said that gender-affirming care is medically necessary and potentially lifesaving, and have called restrictions on it discriminatory.

President Joe Biden, a Democrat, in a 2022 executive order instructed federal agencies like HHS to ensure access to gender-affirming care and prevent discrimination against transgender people.

Republican-led states, meanwhile, have passed a flurry of laws directed at transgender people, including bans on gender-affirming care for minors and restrictions on transgender students' participation in sports.

Last week, a group of Republican states sued the administration over a rule that would bar schools and colleges receiving federal funds from discriminating against transgender students.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.